November 19, 2019
Dr. Goy received the award at the 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow meeting
Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), honored Andre H. Goy, M.D., of John Theurer Cancer Center at Hackensack University Medical Center, with the 2019 Educator of the Year award during the 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow meeting. The ceremony took place on Wednesday, Nov. 6 at the New York Marriott Marquis in New York City.
“We are so honored to recognize fantastic, dynamic and knowledgeable clinicians and researchers like Dr. Goy through the PER® Educator of the Year award,” said Phil Talamo, president of PER®. “On behalf of PER, we thank Dr. Goy for his tremendous spirit and commitment as a teacher, mentor, enthusiast, and overall gentleman in collaborative education for the treatment of cancers.”
Goy is the chairman and executive director of John Theurer Cancer Center at Hackensack University Medical Center. As chief of the division of lymphoma, he leads New Jersey’s largest program for lymphoma treatment, management and research. He holds the position of Professor and Chair of the oncology department at the Seton Hall – Hackensack Meridian School of Medicine.
The PER® Educator of the Year award highlights the accomplishments of oncology leaders and honors their contributions and efforts to propel the field of medical oncology through innovative and collaborative education.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While expanding into topics outside of oncology, PER® stands as the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.